Morphic Holding, Inc. [MORF]

Source: 

Company Overview

Morphic Holding, Inc. operates as a holding company. The Company, through its subsidiaries, develops oral integrin drugs for patients suffering from serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer.